BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16875551)

  • 1. [Natural killer-like T-cell lymphoma/leukemia--a case report and literature review].
    Zhang FK; Wang HJ; Wu YH; Dong SX; Li HQ; Yang DL; Chen HS; Chu YL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):226-30. PubMed ID: 16875551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
    Matsuo Y; Drexler HG
    Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers.
    Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J
    Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.
    Sun T; Brody J; Susin M; Marino J; Teichberg S; Koduru P; Hall WW; Urmacher C; Hajdu SI
    Am J Surg Pathol; 1993 Dec; 17(12):1289-99. PubMed ID: 8238737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
    Mraz-Gernhard S; Natkunam Y; Hoppe RT; LeBoit P; Kohler S; Kim YH
    J Clin Oncol; 2001 Apr; 19(8):2179-88. PubMed ID: 11304770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
    Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
    Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NK-cell lymphomas and NK-like T-cell lymphomas].
    Oshimi K
    Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
    Drexler HG; Matsuo Y
    Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature.
    Luther N; Greenfield JP; Chadburn A; Schwartz TH
    J Neurooncol; 2005 Nov; 75(2):185-8. PubMed ID: 16283442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases.
    Kagami Y; Sobue R; Ito N; Yatabe Y; Taji H; Suzuki R; Seto M; Ogura M; Suchi T; Morishima Y; Nakamura S
    Int J Hematol; 1999 Aug; 70(2):105-11. PubMed ID: 10497849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer-like T-cell lymphoma in a calf.
    Nozaki S; Sasaki K; Ando M; Kadota K
    J Comp Pathol; 2006 Jul; 135(1):47-51. PubMed ID: 16814804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review.
    Lei KI; Chow JH; Johnson PJ
    Clin Oncol (R Coll Radiol); 1997; 9(3):191-4. PubMed ID: 9269556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
    Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK
    Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
    Liu XY; Atkins RC; Feusner JH; Rowland JM
    Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.